Navigation Links
Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
Date:4/28/2011

NEW YORK, April 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

http://www.reportlinker.com/p0487118/Pharmaceutical-Key-Trends-2011---Brand-Erosion-Post-Patent-Expiry.html

Introduction

Pharma is facing slowing sales growth in the developed pharmaceutical markets, driven by increasing generic competition. However, the speed and severity of brand erosion is by no means equal across countries, prescribing setting, therapy area and formulation type; factors which are of key importance when managing and forecasting branded drug sales.

Features and benefits

* Analyzes brand erosion (in terms of volume and value) in the US, Japan, France, Germany, Italy, Spain, UK, Australia China and Russia

* Assesses brand erosion across the two major prescribing settings (retail and hospital)

* Examines brand erosion across the various different therapy areas

* Analyzes brand erosion according to drug formulation (oral, oral long lasting, parenteral and other formulation types)

Highlights

Brands tended not to experience generic erosion in China following patent expiry since they often face generic competition from the outset, and instead continue to grow both in terms of volume and value.

Brand erosion was greater in terms of speed and severity in the hospital setting most likely reflecting the greater brand loyalty among patients in the retail setting.

In terms of erosion by therapy areas, sales and volume erosion was the greatest among infectious disease, oncology, and cardiovascular small molecule brands.

Your key questions answered

* Evaluate the evolving prescription pharmaceutical landscape and how this is being impacted by generics

* Quantify sales and volume erosion across 10 major pharmaceutical markets according to prescribing setting, therapy areas, and drug formulation

* Assess drivers and resistors for the uptake of generic drugs in each market

Executive Summary

Introduction

Strategic Scoping and Focus

Key Findings

Brand erosion by country

Brand erosion by prescribing setting (retail versus hospital)

Brand erosion by therapy area

Brand erosion by formulation

Overview of drugs analyzed

Related Reports

Upcoming related reports

2. BRAND EROSION ACROSS THE WORLD'S MAJOR MARKETS

Overview of brand erosion across the world's major markets

3. GENERICS MARKET DYNAMICS

Comparison of generic penetration across major pharmaceutical markets

Generics volume uptake

Generics value uptake

Generics market size

4. GENERICS DRIVERS AND RESISTORS

Overview of Generics Drivers and Resistors

US – Generics drivers and resistors

Japan – Generics drivers and resistors

France – Generics drivers and resistors

Germany – Generics drivers and resistors

Italy – Generics drivers and resistors

Spain – Generics drivers and resistors

UK – Generics drivers and resistors

China – Generics drivers and resistors

Brazil – Generics drivers and resistors

India – Generics drivers and resistors

Russia – Generics drivers and resistors

Australia – Generics drivers and resistors

5. BRAND EROSION IN THE RETAIL AND HOSPITAL SETTING

Overview of brand erosion in the retail and hospital setting

Retail and hospital erosion by country

6. BRAND EROSION BY THERAPY AREA

Overview of brand erosion by therapy area

Brand erosion by therapy area – Infectious diseases

Brand erosion by therapy area – Cardiovascular

Brand erosion by therapy area – Oncology

Brand erosion by therapy area – Central Nervous System

Brand erosion by therapy area – Respiratory

Brand erosion by therapy area – Metabolic disorders

Brand erosion by therapy area – Immunology and inflammation

Brand erosion by therapy area – Other

7. BRAND EROSION BY DRUG FORMULATION

Overview of brand erosion by drug formulation

Brand erosion by drug formulation – Oral

Brand erosion by drug formulation – Oral long lasting

Brand erosion by drug formulation – Parenteral

Brand erosion by drug formulation – Other formulations

8. BIBLIOGRAPHY

Publications and online articles

Datamonitor reports and products

APPENDIX

Exchange rates used in this report

Brand erosion – methodology

Datamonitor prescription pharmaceutical definition and therapy area classification

To order this report:

: Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):